OncoPharm cover image

PARAMOUNT - Maintenance Pemetrexed

OncoPharm

00:00

PARAMOUNT outcomes: PFS and OS benefit

John Bazar describes PARAMOUNT's improved progression‑free survival and overall survival with maintenance pemetrexed.

Play episode from 06:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app